Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    New revision entry v3.6.3 was added to the history. The previous revision v3.6.2 was removed, updating the documented version trail for the study record.
    Difference
    0.1%
    Check dated 2026-07-04T00:00:01.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record history now includes revision v3.6.2, replacing the prior revision v3.6.0. This reflects an administrative update to the page's versioning rather than a change to trial data or conduct.
    Difference
    0.1%
    Check dated 2026-06-27T01:05:16.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new version v3.6.0 was added with an explicit note that the study is no longer looking for participants. The previous revision v3.5.5 was deleted from the history.
    Difference
    0.5%
    Check dated 2026-06-12T16:02:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.5) was added and the previous tag (v3.5.4) was removed. This updates the page’s version label in the history view to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-06-05T11:15:12.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.5.4 and removes the previous v3.5.3. This updates the page's revision log to reflect the latest version.
    Difference
    0.1%
    Check dated 2026-05-15T04:17:32.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.5.2 to v3.5.3, indicating a new release of the site. This metadata update does not alter the study record content or how the data is displayed.
    Difference
    0.1%
    Check dated 2026-04-30T16:36:54.000Z thumbnail image

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.